Dr. Noah Manuel Devicente, MD

Dr. Devicente practices at West Central Gastroenterology in Tampa, Florida.

Dr. Devicente's NPI, 1336237924, was assigned on October 10, 2006. Dr. Devicente graduated from University Of Florida College Of Medicine in 2004. Dr. Devicente holds Florida license ME107210.

Dr. Devicente's primary practice is West Central Gastroenterology, at 12780 Race Track Rd, Tampa, FL 33626 in Hillsborough County. The practice phone is (727) 347-0005.

Dr. Devicente's primary practice is West Central Gastroenterology in Tampa, Florida. Dr. Devicente is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is Gastro Florida. Dmand AI also links Dr. Devicente to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devicente practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Devicente's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Devicente is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Devicente's licenses on file in 2 states: Florida and South Carolina.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Devicente treats.

CMS data shows 961 Medicare services from Dr. Devicente across 17 procedure codes in 2024, for 514 Medicare patients. Medicare paid $91,649 for them.

CMS counts 514 Medicare patients who saw Dr. Devicente in 2024. The largest group is 65 to 74, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devicente's median patient age at 66, with 54% women.

In 2024, Dr. Devicente wrote 1,464 Medicare Part D claims for 418 patients. 83% of them were for generic drugs. CMS names the drug for 1,268 of them, across 28 drugs with 11 or more claims each, at $157,745 in total drug cost. In 2023, CMS named 1,177 claims across 26 drugs.

Dr. Devicente accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devicente as offering telehealth. CMS counts 126 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Devicente, more than 81% of the clinicians it reports for that procedure.

CMS Open Payments shows 779 general payments to Dr. Devicente from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $4,056.

Dmand AI lists 1 award for Dr. Devicente, most recently CMS Stage 1 EHR in 2013.

Dr. Devicente graduated from University Of Florida College Of Medicine in 2004.

Dr. Devicente is in network with 18 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.